Expression of CD94/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanoma

Journal of Investigative Dermatology

Volumn 114, Issue 5, 2000, Pages 941-947

  Vetter, Claudia S ^a   Terheyden, Patrick ^a   Bröcker, Eva B ^a   Becker, Jürgen C ^a   Straten, Perthor ^b   Zeuthen, Jesper ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

Cytotoxic T lymphocyte; Natural killer receptor; T cell response

Indexed keywords

CD8 ANTIGEN; CD94 ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MALE; MELANOMA CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

EID: 0034070960     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00958.x     Document Type: Article

References (46)

1. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T: Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285:727-729, 1999
2. Becker JC, Brabletz T, Kirchner T, Conrad CT, Brocker EB, Reisfeld RA: Negative transcriptional regulation in anergic T cells. Proc Natl Acad Sci USA 92:2375-2378, 1995
3. Becker JC, Guldberg P, Zeuthen J, Brocker EB, thor-Straten P: Accumulation of identical T cells in melanoma and vitiligo-like leukoderma. J Invest Dermatol 113:1033-1038, 1999
4. Bertone S, Schiavetti F, Bellomo R, Vitale C, Ponte M, Moretta L, Mingari MC: Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes. Eur J Immunol 29:23-29, 1999
5. Borrego F, Ulbrecht M, Weiss EH, Cohgan JE, Brooks AG: Recognition of human histocompatibility leukocyte antigen (HLA) -E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med 187:813-818, 1998
6. Brooks AG, Borrego F, Posch PE, et al: Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells. J Immunol 162:305-313, 1999
7. Chang C, Rodriguez A, Carretero M, Lopez-Botet M, Phillips JH, Lanier LL: Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur J Immunol 25:2433-2437, 1995
8. Chien YH, Davis MM: How alpha beta T-cell receptors "see" peptide/MHC complexes. Immunol Today 14:597-602, 1993
9. Colonna M, Samaridis J: Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 268:405-408, 1995
10. De-Smet C, Lurquin C, De-Plaen E, et al: Genes coding for melanoma antigens recognised by cytolytic T lymphocytes. Eye 11:243-248, 1997
11. Faure F, Even J, Kourilsky P: Tumor-specific immune response: current in vitro analyses may not reflect the in vivo immune status. Crit Rev Immunol 18:77-86, 1998
12. Ferrone S, Marincola FM: Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol Today 16:487-494, 1995
13. Glienke J, Sobanov Y, Brostjan C, et al: The genomic organization of NKG2C, E, F, and D receptor genes in the human natural killer gene complex. Immunogenetics 48:163-173, 1998
14. Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T: Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci USA 96:6879-6884, 1999
15. Halary F, Peyrat MA, Champagne E, et al: Control of self-reactive cytotoxic T lymphocytes expressing gamma delta T cell receptors by natural killer inhibitory receptors. Eur J Immunol 27:2812-2821, 1997
16. Hamann D, van Roos MT, Lier RA: Faces and phases of human CD8 T-cell development. Immunol Today 20:177-180, 1999
17. Ho EL, Heusel JW, Brown MG, Matsumoto K, Scalzo AA, Yokoyama WM: Murine Nkg2d and Cd94 are clustered within the natural killer complex and are expressed independently in natural killer cells. Proc Natl Acad Sci USA 95:6320-6325, 1998
18. Ikeda H, Lethe B, van Lehmann F, et al: Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 6:199-208, 1997
19. Isakov N: ITIMs and ITAMs. The Yin and Yang of antigen and Fc receptor-linked signaling machinery. Immunol Res 16:85-100, 1997
20. Lanier LL: Natural killer cells: from no receptors to too many. Immunity 6:371-378, 1997
21. Lanier LL: NK cell receptors. Annu Rev Immunol 16:359-393, 1998
22. Lanier LL, Corliss B, Wu J, Phillips JH: Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 8:693-701, 1998
23. Lee N, Llano M, Carretero M, Ishitani A, Navarro F, Lopez-Botet M, Geraghry DE: HLA-E is a major ligand for the natural killer inhibitory receptor CD94/ NKG2A. Proc Natl Acad Sci USA 95:5199-5204, 1998
24. Ljunggren HG, Karre K: In search of the "missing self": MHC molecules and NK cell recognition. Immunol Today 11:237-244, 1990
25. Lopez-Botet M, Bellon T: Natural killer cell activation and inhibition by receptors for MHC class I. Curr Opin Immunol 11:301-307, 1999
26. Lopez-Botet M, Carretero M, Bellon T, Perez-Villar JJ, Llano M, Navarro F: The CD94/NKG2 C-type lectin receptor complex. Curr Top Microbiol Immunol 230:41-52, 1998
27. Matzinger P: Tolerance, danger, and the extended family. Annu Rev Immunol 12:991-1045, 1994
28. Meyaard L, Adema GJ, Chang C, Woollatt E, Sutherland GR, Lanier LL, Phillips JH: LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity 7:283-290, 1997
29. Mingari MC, Vitale C, Cambiaggi A, Schiavetti F, Melioli G, Ferrini S, Poggi A: Cytolytic T lymphocytes displaying natural killer (NK) -like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. Int Immunol 7:697-703, 1995
30. Mingari MC, Schiavetti F, Ponte M, et al: Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc Natl Acad Sci USA 93:12433-12438, 1996
31. Mingari MC, Moretta A, Moretta L: Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses. Immunol Today 19:153-156, 1998
32. Moretta A, Bottino C, Vitale M, Pende D, Biassoni R, Mingari MC, Moretta L: Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol 14:619-648, 1996
33. Moretta A, Sivori S, Ponte M, Mingari MC, Moretta L: Stimulatory receptors in NK and T cells. Curr Top Microbiol Immunol 230:15-23, 1998
34. Noppen C, Schaefer C, Zajac P, et al: C-type lectin-like receptors in peptide-specific HLA class I-restricted cytotoxic T lymphocytes: differential expression and modulation of effector functions in clones sharing identical TCR structure and epitope specificity. Eur J Immunol 28:1134-1142, 1998
35. Pardoll DM: Inducing autoimmune disease to treat cancer. Proc Natl Acad Sci USA 96:5340-5342, 1999
36. Pende D, Biassoni R, Cantoni C, et al: The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J Exp Med 184:505-518, 1996
37. Phillips JH, Gumperz JE, Parham P, Lanier LL: Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 268:403-405, 1995
38. Plougastel B, Jones T, Trowsdale J: Genomic structure, chromosome location, and alternative splicing of the human NKG2A gene. Immunogenetics 44:286-291, 1996
39. Raulet DH: Does a low level of expression of HLA molecules engender autoimmunity? N Engl J Med 340:314-315, 1999
40. Sobanov Y, Glienke J, Brostjan C, Lehrach H, Francis F, Hofer E: Linkage of the NKG2 and CD94 receptor genes to D12S77 in the human natural killer gene complex. Immunogenetics 49:99-105, 1999
41. Speiser DE, Pittet MJ, Valmori D, et al: In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes. J Exp Med 190:775-782, 1999a
42. Speiser DE, Valmori D, Rimoldi D, et al: CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients. Eur J Immunol 29:1990-1999, 1999b
43. thor-Straten P, Becker JC, Guldberg P, Zeuthen J: In situ T cells in melanoma. Cancer Immunol Immunother 48:386-395, 1999
44. Valiante NM, Uhrberg M, Shilling HG, et al: Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7:739-751, 1997
45. Vitale M, Bottino C, Sivori S, et al: NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med 187:2065-2072, 1998
46. Wagner SN, Schultewolter T, Wagner C, Briedigkeit L, Becker JC, Kwasnicka HM, Goos M: Immune response against human primary malignant melanoma: a distinct cytokine mRNA profile associated with spontaneous regression. Lab Invest 78:541-550, 1998